Literature DB >> 9208846

Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b.

S Huang1, Y Jiang, Z Li, E Nishida, P Mathias, S Lin, R J Ulevitch, G R Nemerow, J Han.   

Abstract

Fas/APO-1(CD95) ligation activates programmed cell death, a cellular process that plays an important role in the maturation of the host immune response. We show that activation of a specific MAP kinase kinase (MKK), MKK6b, is necessary and sufficient for Fas-induced apoptosis of Jurkat T cells. MKK6b activation occurs downstream of an interleukin-1 converting enzyme-like (ICE-like) protease(s), while execution of the apoptotic pathway by MKK6b requires both ICE- and CPP32-like proteases. Surprisingly, the p38 MAP kinase protein, a known substrate of MKK6b, does not participate in Fas/MKK6b-mediated apoptosis. These findings indicate a divergence of the MKK6b signaling pathways, one of which activates p38 and leads to regulation of gene expression, and one of which activates the ICE/Ced-3 family of proteases and leads to cell death. These studies represent a demonstration of an apoptotic pathway that is comprised of both the ICE/Ced-3 family of proteases and MAP kinase kinase 6.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9208846     DOI: 10.1016/s1074-7613(00)80449-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  66 in total

1.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

Review 3.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

4.  Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.

Authors:  Han Liu; Ali Pedram; Jin Kyung Kim
Journal:  Cardiovasc Res       Date:  2010-08-19       Impact factor: 10.787

5.  Phosphorylation of Raptor by p38beta participates in arsenite-induced mammalian target of rapamycin complex 1 (mTORC1) activation.

Authors:  Xiao-Nan Wu; Xue-Kun Wang; Su-Qin Wu; Jiawei Lu; Min Zheng; Yan-Hai Wang; Huamin Zhou; Hongbing Zhang; Jiahuai Han
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

6.  Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells.

Authors:  T Shuto; H Xu; B Wang; J Han; H Kai; X X Gu; T F Murphy; D J Lim; J D Li
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

7.  Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy.

Authors:  S Nemoto; Z Sheng; A Lin
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

8.  Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.

Authors:  M Rincón; H Enslen; J Raingeaud; M Recht; T Zapton; M S Su; L A Penix; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

9.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

10.  Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.

Authors:  Vered Levin-Salomon; Konstantin Kogan; Natalie G Ahn; Oded Livnah; David Engelberg
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.